Adaptive Biotechnologies Corp — Form D
Adaptive Biotechnologies Corp of SEATTLE, WA, a company, filed a Form D exempt-offering notice with the SEC on 2015-01-22. The offering totals $93.8M, of which $93.8M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2015-01-22
- Form: D
- Accession: 0001478320-15-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $93.8M
- Amount sold: $93.8M
- Investors: 4
- Date of first sale: 2015-01-07
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-232659
Issuer
- Name: Adaptive Biotechnologies Corp
- CIK: 0001478320
- Entity type: Corporation
- Jurisdiction: WASHINGTON
- Incorporated: 2009
- Address: 1551 EASTLAKE AVENUE EAST SUITE 200, SEATTLE, WA, 98102
- Phone: 206-659-0067
Officers, directors & promoters (18)
| Name | Role | Location |
|---|
| Lee Huntsman | Director | Seattle, WA |
| Harlan Robins | Director | Seattle, WA |
| Harlan Robins | Executive Officer | Seattle, WA |
| Chad Robins | Director | Seattle, WA |
| Chad Robins | Executive Officer | Seattle, WA |
| ARNOLD LEVINE | Director | Durham, NC |
| Rob Rosen | Director | Washington, DC |
| Peter Neupert | Director | RALEIGH, NC |
| Tom Willis | Director | South San Francisco, CA |
| Chris Carlson | Executive Officer | Sioux Falls, SD |
| Craig Weissman | Director | SAN FRANCISCO, CA |
| Andris Zoltners | Director | SEATTLE, WA |
| Kathleen Determann | Executive Officer | SEATTLE, WA |
| Rob Hershberg | Director | SEATTLE, WA |
| Dean Schorno | Executive Officer | SEATTLE, WA |
| John Stuelpnagel | Director | SEATTLE, WA |
| Chad Cohen | Director | SEATTLE, WA |
| Andy Zoltners | Director | Seattle, WA |
Other filings by this issuer (8)
More